Retaglutide is a innovative GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://phoenixijig206735.ambien-blog.com/45736316/retaglutide-a-promising-glp-1-receptor-agonist